R. Marcén

Transplantation · 2009

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom R. Marcén trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. A. Macdonald
  2. B. Kasiske

Who trusts R. Marcén overall

  1. Marcello Tonelli

Papers from R. Marcén's perspective

Ordered by how strongly the researchers R. Marcén trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor (Nature Medicine)
  2. Cancer after Kidney Transplantation in the United States (American Journal of Transplantation)
  3. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. (New England Journal of Medicine)
  4. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. (New England Journal of Medicine)
  5. Hepatocellular carcinoma: an epidemiologic view. (Journal of Clinical Gastroenterology)
  6. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis (British Journal of Cancer)
  7. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. (New England Journal of Medicine)
  8. Going from evidence to recommendations (British medical journal)
  9. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. (Kidney International)
  10. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Their papers